411 related articles for article (PubMed ID: 12475001)
21. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M
Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571
[TBL] [Abstract][Full Text] [Related]
22. Complete congenital heart block followed by anti-Ro/SSA in adult life. Studies of an informative family.
Reichlin M; Friday K; Harley JB
Am J Med; 1988 Feb; 84(2):339-44. PubMed ID: 3261539
[TBL] [Abstract][Full Text] [Related]
23. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
[TBL] [Abstract][Full Text] [Related]
24. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
25. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of mothers of children with complete congenital heart block.
Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
[TBL] [Abstract][Full Text] [Related]
27. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus.
Niewold TB; Rivera TL; Buyon JP; Crow MK
Arthritis Rheum; 2008 Feb; 58(2):541-6. PubMed ID: 18240214
[TBL] [Abstract][Full Text] [Related]
28. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
[TBL] [Abstract][Full Text] [Related]
29. Fetal wastage in women with anti-Ro(SSA) antibody.
Watson RM; Braunstein BL; Watson AJ; Hochberg MC; Provost TT
J Rheumatol; 1986 Feb; 13(1):90-4. PubMed ID: 3486290
[TBL] [Abstract][Full Text] [Related]
30. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
[TBL] [Abstract][Full Text] [Related]
31. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
Makino S; Yonemoto H; Itoh S; Takeda S
Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
[No Abstract] [Full Text] [Related]
32. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
Al Arfaj AS; Khalil N
Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
[TBL] [Abstract][Full Text] [Related]
34. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
35. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
[TBL] [Abstract][Full Text] [Related]
36. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
[TBL] [Abstract][Full Text] [Related]
37. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
Yang CH; Chen JY; Lee SC; Luo SF
J Microbiol Immunol Infect; 2005 Oct; 38(5):365-9. PubMed ID: 16211147
[TBL] [Abstract][Full Text] [Related]
38. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
39. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
[TBL] [Abstract][Full Text] [Related]
40. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]